New Delhi, Oct. 18 -- PrecisionRNA Biotech Pvt. Ltd. (Prerna), a leading healthcare innovation company from Hyderabad, today announced the launch of Cantel™, India's first microRNA-based blood test for breast cancer screening. This groundbreaking test is set to transform early detection by offering a simple, convenient, and highly accurate alternative to traditional methods, addressing the critical screening gap that has led to late-stage diagnosis of breast cancer in India.

"For far too long, breast cancer detection in India has been reactive. With Cantel™, we're making it proactive, accessible, and designed around women's real lives, empowering them to take control of their health with confidence and ease." said Siddharth R...